197 related articles for article (PubMed ID: 21654731)
1. Mosaics and moles.
Sunde L; Niemann I; Hansen ES; Hindkjaer J; Degn B; Jensen UB; Bolund L
Eur J Hum Genet; 2011 Oct; 19(10):1026-31. PubMed ID: 21654731
[TBL] [Abstract][Full Text] [Related]
2. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
3. Twin pregnancies with diploid hydatidiform mole and co-existing normal fetus may originate from one oocyte.
Niemann I; Bolund L; Sunde L
Hum Reprod; 2008 Sep; 23(9):2031-5. PubMed ID: 18556678
[TBL] [Abstract][Full Text] [Related]
4. Androgenetic/biparental mosaicism in a diploid mole-like conceptus: report of a case with triple paternal contribution.
Donzel M; Gaillot-Durand L; Joubert M; Aziza J; Beneteau C; Mauduit C; Ploteau S; Hajri T; Bolze PA; Massardier J; Devouassoux-Shisheboran M; Sunde L; Allias F
Virchows Arch; 2023 Nov; 483(5):709-715. PubMed ID: 37695410
[TBL] [Abstract][Full Text] [Related]
5. Aneuploidy is frequent in heterozygous diploid and triploid hydatidiform moles.
Walbum P; Andreasen L; Geilswijk M; Niemann I; Sunde L
Sci Rep; 2024 Mar; 14(1):6876. PubMed ID: 38519579
[TBL] [Abstract][Full Text] [Related]
6. Diploid hydatidiform moles with fetal red blood cells in molar villi. 2--Genetics.
Fisher RA; Paradinas FJ; Soteriou BA; Foskett M; Newlands ES
J Pathol; 1997 Feb; 181(2):189-95. PubMed ID: 9120724
[TBL] [Abstract][Full Text] [Related]
7. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
Niemann I; Hansen ES; Sunde L
Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
[TBL] [Abstract][Full Text] [Related]
8. Paternal Hemizygosity in 11p15 in Mole-like Conceptuses: Two Case Reports.
Sunde L; Lund H; J Sebire N; Grove A; Fisher RA; Niemann I; Kjeldsen E; Andreasen L; Hansen ES; Bojesen A; Bolund L; Nyegaard M
Medicine (Baltimore); 2015 Nov; 94(44):e1776. PubMed ID: 26554776
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotyping.
Banet N; DeScipio C; Murphy KM; Beierl K; Adams E; Vang R; Ronnett BM
Mod Pathol; 2014 Feb; 27(2):238-54. PubMed ID: 23887308
[TBL] [Abstract][Full Text] [Related]
10. When to Consult a Geneticist Specialising in Gestational Trophoblastic Disease.
McMahon L; Maher GJ; Joyce C; Niemann I; Fisher R; Sunde L
Gynecol Obstet Invest; 2024; 89(3):198-213. PubMed ID: 37245506
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of hydatidiform moles using circulating gestational trophoblasts isolated from maternal blood.
Ravn K; Hatt L; Singh R; Schelde P; Hansen ES; Vogel I; Uldbjerg N; Niemann I; Sunde L
Placenta; 2023 Apr; 135():7-15. PubMed ID: 36889013
[TBL] [Abstract][Full Text] [Related]
12. Genetics of gestational trophoblastic disease.
Fisher RA; Maher GJ
Best Pract Res Clin Obstet Gynaecol; 2021 Jul; 74():29-41. PubMed ID: 33685819
[TBL] [Abstract][Full Text] [Related]
13. Mosaic moles and non-familial biparental moles are not caused by mutations in NLRP7, NLRP2 or C6orf221.
Andreasen L; Bolund L; Niemann I; Hansen ES; Sunde L
Mol Hum Reprod; 2012 Dec; 18(12):593-8. PubMed ID: 22909446
[TBL] [Abstract][Full Text] [Related]
14. [A study for the genesis of trophoblastic tumor, with reference to its androgenetic origin].
Wake N
Hokkaido Igaku Zasshi; 1984 Jan; 59(1):21-7. PubMed ID: 6325316
[TBL] [Abstract][Full Text] [Related]
15. [Cytogenetic, morphological and clinical studies on partial hydatidiform moles].
Ueda K
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1071-80. PubMed ID: 4031566
[TBL] [Abstract][Full Text] [Related]
16. NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation.
Deveault C; Qian JH; Chebaro W; Ao A; Gilbert L; Mehio A; Khan R; Tan SL; Wischmeijer A; Coullin P; Xie X; Slim R
Hum Mol Genet; 2009 Mar; 18(5):888-97. PubMed ID: 19066229
[TBL] [Abstract][Full Text] [Related]
17. Genomic imprinting in gestational trophoblastic disease--a review.
Fisher RA; Hodges MD
Placenta; 2003 Apr; 24 Suppl A():S111-8. PubMed ID: 12842422
[TBL] [Abstract][Full Text] [Related]
18. Involvement of IGF2 and H19 imprinting in choriocarcinoma development.
Wake N; Arima T; Matsuda T
Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S1-8. PubMed ID: 9833609
[TBL] [Abstract][Full Text] [Related]
19. Single-nucleotide polymorphism array and fluorescence in situ hybridization analysis to decode the cytogenetic profile of atypical partial hydatidiform moles diagnosed by short tandem repeat polymorphism analysis.
Suzuki Y; Usui H; Katayama E; Sato A; Nakamura N; Nakada E; Omoto A; Okayama J; Sato M; Nagasawa A; Hirosawa A; Shozu M; Koga K
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23220. PubMed ID: 38780072
[TBL] [Abstract][Full Text] [Related]
20. Detection of Parental Contribution to Molar Genome Leads to Diagnosis of Recurrent Hydatidiform Mole in a Family with
Wang RY; Li YJ; Zhen L; Jiang F; Gu CM; Li DZ
Fetal Pediatr Pathol; 2022 Jun; 41(3):511-515. PubMed ID: 33252287
[No Abstract] [Full Text] [Related]
[Next] [New Search]
